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The ability to microdissect individual cells from the nervous system has enormous potential, as it can allow for the study of gene
expression in phenotypically identified cells. However, if the resultant gene expression profiles are to be accurately ascribed, it is
necessary to determine the extent of contamination by nontarget cells in the microdissected sample. Here, we show that midbrain
dopamine neurons can be laser-microdissected to a high degree of enrichment and purity. The average enrichment for tyrosine
hydroxylase (TH) gene expression in the microdissected sample relative to midbrain sections was approximately 200-fold. For the
dopamine transporter (DAT) and the vesicular monoamine transporter type 2 (Vmat2), average enrichments were approximately
100- and 60-fold, respectively. Glutamic acid decarboxylase (Gad65) expression, a marker for GABAergic neurons, was several
hundredfold lower than dopamine neuron-specific genes. Glial cell and glutamatergic neuron gene expression were not detected
in microdissected samples. Additionally, SN and VTA dopamine neurons had significantly different expression levels of dopamine
neuron-specific genes, which likely reflects functional differences between the two cell groups. This study demonstrates that it is
possible to laser-microdissect dopamine neurons to a high degree of cell purity. Therefore gene expression profiles can be precisely
attributed to the targeted microdissected cells.
1. Introduction
The midbrain dopamine system, comprising the nigrostri-
atal, mesocortical, and mesolimbic pathways, is involved in
many brain functions, such as motor control, cognition,
and reward behaviors [1]. Dysfunction or degeneration of
midbrain dopamine neurons is associated with a number of
neurological conditions including Parkinson’s disease (PD),
cognitive impairment, and addiction. One way to probe
the mechanisms associated with both normal and abnor-
mal functions of the dopamine system is to characterize
the molecular profile of dopamine neurons themselves.
The advent of laser microdissection has made this possi-
ble. For example, dopamine neurons have been microdis-
sected, and gene expression profiles have been compared
between ventral tegmental area (VTA) subpopulations [2]
and between dopamine and other catecholaminergic neurons
[3]. However, while various neuronal identification and laser
microdissection methods have been employed to segregate
dopamine neurons from surrounding brain tissue, the critical
issue of sample purity has not been adequately addressed.
There is considerable cellular heterogeneity within the
substantia nigra (SN) and VTA regions of the midbrain.
Stereological estimates of GABA and dopamine neuron
populations in SN and VTA indicate that there are more
GABA than dopamine neurons, and in some subregions
there are nearly three times as many [4]. Additionally, in
the VTA, glutamate neurons intermingle with the dopamine
neuronpopulation [4, 5].Therefore, there is a very real chance
for cross-contamination during microdissection of targeted
dopamine neurons. At a minimum, the degree to which the
targeted population is contaminated with unwanted cells or
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cell fragments must be known if meaningful interpretations
of molecular profiles are to be made. This is particularly
important when the gene(s) of interest are expressed at
relatively low levels in the target population (e.g., dopamine
neurons) but are relatively highly expressed in surrounding
cells that might be inadvertently included in the microdis-
sected sample (e.g., GABA or glutamate neurons).
Recent studies have demonstrated the potential of
dopamine neuron microdissection. For example, Liss and
colleagues were able to distinguish midbrain dopamine
neuron subpopulations on the basis of tyrosine hydroxylase
(TH), vesicular monoamine transporter type 2 (Vmat2), and
dopamine transporter (DAT) transcript expression ratios [2]
and, in a separate study, demonstrated increased 𝛼-synuclein
transcript levels in SN dopamine neurons from PD brains
[6]. Such comparisons could not be readily made without
microdissection. However, in neither of these studies was the
extent of contamination by nondopamine cells adequately
determined [2, 6]. The molecular analysis for cell purity was
qualitative and insensitive compared to quantitative poly-
merase chain reaction (qPCR) methods. Also, the apparent
purity may have resulted from the relative homogeneity of
the target SNpc dopamine group, where dopamine neurons
outnumber GABA neurons by nearly threefold [4]. Further-
more, SNpc dopamine neurons are relatively large and easy
to visually differentiate, even with Nissl, a noncell-specific
label. In contrast, VTA dopamine neuron subpopulations
consist of cells not readily identifiable on the basis of size and
location.Therefore, if stringent analyses are required for these
subpopulations [7], reliable and accurate identification of
dopamine neurons through immunolabeling for a dopamine-
specific marker, such as TH, is necessary.
We have previously reported a method that permits
the extraction of high quality RNA from immunolabeled,
microdissected cells [8]. The primary aim of the present
study was to assess the cellular purity of laser-microdissected
dopamine neurons that were obtained following immunola-
beling for TH using this method of RNA preservation. Our
results show that relatively large numbers of dopamine neu-
rons can be isolated from the surrounding tissue to produce
a sample that contains a highly enriched and relatively pure
population of dopamine neurons. In addition, we compared
the molecular profiles of SN and VTA dopamine neurons.
2. Materials and Methods
2.1. Tissue Immunolabeling and Preparation for Laser
Microdissection. All animal work was carried out in strict
accordance with institutional, state, and national animal
ethics regulations. Tissue preparation and identification of
midbrain dopamine neurons by TH immunofluorescence
was carried out essentially as described [8]. Briefly, ten
micron thick midbrain cryosections, archived at –80∘C,
were rinsed in PBS (15 secs) and then fixed in acetone
(5min). Acetone was removed by a rapid PBS rinse and
the slide placed in 2MNaCl PBS. Sections were incubated
overnight at 4∘C with mouse anti-TH monoclonal antibody
(MAB318, Chemicon, Millipore), diluted 1 : 50 in 2MNaCl
PBS. Unbound primary antibody was removed by rinsing
with 2M NaCl in PBS (5min). Sections were then incubated
overnight at 4∘C with Alexa Fluor 488 conjugated donkey
anti-mouse (Invitrogen), at 1 : 100 in 2MNaCl PBS. Unbound
secondary antibody was removed by a 2MNaCl PBS rinse.
Immediately prior to microdissection, excess NaCl was
removed by a rapid PBS rinse, and sections were then
dehydrated twice in 100% ethanol (1min each) and then
delipidated twice in xylene (2min each). With the exception
of the room temperature ethanol and xylene, all solutions
were ice-cold. All PBS solutions were diethyl pyrocarbonate
(DEPC) treated.
2.2. Laser Microdissection and RNA Extraction. Laser
microdissection and pressure catapulting of dopamine
neurons were carried out using a PALM MicroBeam system
(Zeiss). Briefly, TH immunolabeled midbrain dopamine
neurons were visualised with the system’s Axiovert 200M
inverted fluorescent microscope. The UVA laser was then
focused in the plane of the tissue section, and the cell body
was separated from surrounding tissue using laser ablation to
remove a thin line of tissue at the cell body border. Removal
of the cell body from the glass slide was accomplished
through defocussing the laser beam and pressure catapulting
cells into lysis buffer contained in a PCR tube lid, mounted
directly above the cells of interest. For both laser cutting
and catapulting, the minimum amount of laser energy was
used to achieve separation of the cell from its surrounding
tissue (laser cutting) and for removal of the cell from the
microscope slide (laser catapulting). For each animal a
total of three hundred dopamine cell bodies from each
of the SN and VTA were UVA laser microdissected. To
minimize the length of time tissue sections were held on the
microdissection microscope stage, and cells were pressure
catapulted into 30 𝜇L RLT lysis buffer (RNeasy, Qiagen) in
lots of 100. Following cell collection, lysis buffer volume
was increased to 100 𝜇L, and the sample homogenized by
vortexing and then placed at −80∘C for later use. Prior to
RNA extraction, the three 100 dopamine neuron samples
were combined, and total RNA was extracted using the
RNeasy microkit (Qiagen) according to manufacturer’s
instructions, including addition of poly-A carrier RNA to
the lysate and an on-column DNAse-I treatment.
2.3. Reverse Transcription and qPCR of Laser-Microdissected
Sample. Reverse transcription was carried out using Super-
Script III (Invitrogen), according to manufacturer’s instruc-
tions and as previously described [8]. Two-thirds of the total
RNA extracted was used in a 20𝜇L RT+ cDNA synthesis
reaction, with the remaining third used in the RT− reaction.
One microliter of cDNA product was added to each qPCR
reaction, with the qPCR protocol, and all other reagents
and volumes as described [8]. Primer sequences are listed
in Table 1. The entire process of dopamine neuron laser
microdissection and qPCRwas carried out three independent
times. qPCR reactions were run in triplicate for each gene.
The 18S ribosomal RNA gene was chosen for normalization
and the delta Ct ((ΔCt) threshold cycle) was determined for
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Table 1: Sequences for qPCR primers.
Gene name Gene ID Forward primer Reverse primer
18S ribosomal RNA 18S rRNA CCCGAAGCGTTTACTTTGAA CCCTCTTAATCATGGCCTCA
Dopamine transporter (DAT) Slc6a3 GCCCATTTATGCGACCTACA GATGGTCTTTCTCAGGTGTGATG
Tyrosine hydroxylase TH TGTGTCCGAGAGCTTCAATG GCTGGATACGAGAGGCATAGTTC
Glial fibrillary acidic protein Gfap CAACCTCCAGATCCGAGAAA GCTCCTGCTTCGACTCCTTA
Nuclear orphan receptor (Nurr1) Nr4a2 CGATCAGGACCTGCTTTTTG CTGGGTTGGACCTGTATGCT
Vesicular monoamine transporter 2 (Vmat2) Slc18a2 AGACCATGTGTTCCCGAAAG CACATAGCCACCTTCCCATT
Glutamic acid decarboxylase 65 (GAD65) Gad2 TTGCGAGTTCTGGAAGACAA AGATGACCATGCGGAAGAAG
Vesicular glutamate transporter 2 (VGlut2) Slc17a6 GATATTGCCCCGAGATATGC CCATTCTTCACGGGACTTGT
each gene relative to 18S. The ΔΔCt method [9] was used
for gene expression comparisons between whole midbrain
sections and laser-microdissected dopamine neurons and
between SN and VTA dopamine populations.
2.4. RNA Extraction, Reverse Transcription, and qPCR of
WholeMidbrain Sections. To enable assessment of dopamine
neuron enrichment conferred by microdissection, total RNA
from whole midbrain sections (containing dopamine neu-
rons) was extracted, contaminating genomic DNA removed
by on-column DNase-I digestion using Qiagen’s RNeasy
microkit and DNase reagents according to manufacturer’s
instructions.The concentration of total RNAwas determined
using Thermo Scientific NanoDrop 1000 spectrophotome-
ter. Reverse transcription and qPCR were carried out as
described above, with 60 ng of RNA added to 20𝜇L RT+ and
RT− cDNA synthesis reactions and 1 ng of cDNA added to
each qPCR reaction.
2.5. Statistical Analysis. To assess purity and enrichment of
the microdissected population, a comparison between whole
midbrain sections and either SN or VTA lasermicrodissected
dopamine neurons was made using an unpaired Student’s
𝑡-test for each gene. A comparison of the SN and VTA
dopamine neuron molecular profiles was also statistically
analyzed using an unpaired Student’s 𝑡-test. An alpha level of
.05 was applied for all statistical tests.
3. Results
3.1. Purity and Enrichment of Laser-Microdissected Midbrain
Dopamine Neurons. As is evident from Figure 1 and con-
sistent with our previous work [8], midbrain dopamine
neurons, immunofluorescently labeled using high salt buffer
for RNA preservation, were readily identified and laser
microdissected from 10micron thick sections. Approximately
300 SN and 300 VTA dopamine cell bodies were collected for
downstream molecular analysis for each experiment. RNA
was also extracted from dopamine neuron-containing, whole
midbrain sections located on the same microscope slide as
sections used for dopamine neuron microdissection. This
allowed enrichment and purity assessments and RNA quality
controls to be carried out.
To determine the level of purity of the microdissected
cells, relative expression levels for dopamine-related and
nondopamine-related genes were quantified. The dopamine
neuron-specific genes were those encoding the dopamine
transporter (Slc6a3/DAT), tyrosine hydroxylase (TH), vesic-
ular monoamine transporter type 2 (Slc18a2/Vmat2), and the
nuclear orphan receptor (Nr4a2/NURR1).The nondopamine
neuron-specific genes were the glutamate neuron-specific
vesicular glutamate transporter type 2 (Slc17a6/Vglut2),
the GABA neuron-specific glutamic acid decarboxylase 65
(Gad2/Gad65), and the glial cell-specific glial fibrillary acidic
protein (Gfap). The relative expression levels of all dopamine
neuron-related transcripts were significantly increased in the
SN and VTA microdissected dopamine neurons compared
to whole sections, with DAT being 104- and 95-, TH 147-
and 249-, Vmat2 60- and 57-, and NURR1 4- and 10-fold
enriched in SN and VTA, respectively (Figure 2). Neither
expression of the glutamate neuron gene, Slc17a6/Vglut2, nor
that of the glial gene, Gfap, was detected in either the SN or
VTA microdissected dopamine neuron samples. In contrast,
expression of the GABA neuron gene, Gad65, was detected
in both the SN and VTA microdissected dopamine neuron
samples (Figure 2). However, its abundancewas relatively low
compared to dopamine neuron-specific genes. For example,
Gad65 in both the SN and VTA microdissected dopamine
neuron samples was several hundredfold less abundant than
TH.
3.2. Comparison of SN and VTA Dopamine Neuron Expres-
sion Profiles. The midbrain SN and VTA dopamine neuron
populations are, for the most part, anatomically separate. It
is possible, therefore, to microdissect the dopamine neurons
of the two populations and carry out a comparative analysis.
Firstly, we compared expression levels of the dopamine
neurotransmission-related genes (TH, DAT, and Vmat2)
within each of the two populations and for both the SN and
VTA. TH expression was significantly higher than DAT (𝑃 <
0.01) and DAT expression significantly higher than Vmat2
(𝑃 < 0.01), and this was the case for both SN and VTA. The
relative expression for each gene between the SN and VTA
was then compared. Figure 3 shows there was no significant
difference in expression of DAT and Vmat2 between the
SN and VTA dopamine neurons. However, for TH and
NURR1, the VTA dopamine neurons showed a 1.8- and 2.5-
fold increase over SN dopamine neurons, respectively. Lastly,
the relative expression ratios for dopamine neuron-specific
transcripts were compared between the SN and VTA. The
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(a) (b)
Figure 1: Ventral midbrain showing dopamine neurons identified by tyrosine hydroxylase immunofluorescent labeling. Fresh-frozen brains
were cryosectioned at 10 microns, acetone fixed, and immunolabeled in high salt buffer, prior to dehydration and delipidation in preparation
for laser microdissection using a Zeiss LMD system. (a) Prior to microdissection. (b) Following selection and laser microdissection of several
immunofluorescent dopamine neurons. Dashed outlines indicate where the dopamine cell bodies were laser-captured from. A number of
labeled dopamine neurons remain for reference.
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Figure 2: Assessment of dopamine neuron sample enrichment and purity by qPCR. The graph column title, “Sections,” refers to midbrain
sections that have not been altered in terms of cellular content and therefore contain dopamine neurons and many other cell types. They
constitute an appropriate reference for the estimation of enrichment and purity of a population of cells isolated from midbrain sections.
Increased expression of the dopaminergic genes: DAT (a), TH (b), Vmat2 (c), and NURR1 (d), in SN and VTA laser-microdissected samples
relative to whole midbrain sections is indicative of dopamine neuron enrichment. A significant reduction in expression of the GABA gene,
GAD65 (e), and the lack of detection of the genes encoding for vesicular glutamate transporter 2 (Vglut2), and the glial gene, Gfap (data not
shown), within the SN and VTA suggests isolation of a relatively pure population of dopamine neurons.The Ct for each gene was normalized
to the Ct for the 18S rRNA reference gene, and data are presented as mean fold change in expression relative to sections ± SEM. Asterisks
indicate significant difference to whole midbrain sections. ∗𝑃 ≤ 0.05, ∗∗𝑃 ≤ 0.01, and ∗∗∗𝑃 ≤ 0.001; 𝑛 = 3.
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Figure 3: The relative gene expression profiles of laser-microdissected SN and VTA dopamine neurons. Expression levels were compared
using qPCR for dopamine neuron genes: DAT (a); TH (b); Vmat2 (c); NURR1 (d); and the GABA neuron gene, GAD65 (e). Note, significantly
different expression levels were only found for TH and NURR1 transcripts, where there was an increase in VTA microdissected dopamine
neurons relative to SN. The Ct for each gene was normalized to the Ct for the 18S rRNA reference gene, and data are presented as mean fold
change in expression relative to SN ± SEM. Asterisks indicate significant difference relative to SN. ∗𝑃 ≤ 0.05, ∗∗𝑃 ≤ 0.01, and ∗∗∗𝑃 ≤ 0.001;
𝑛 = 3.
DAT/TH ratio was significantly lower in VTA compared to
SN dopamine neurons (Figure 4; 𝑃 < 0.01), there was no
significant difference in the DAT/Vmat2 ratio between the
two regions (Figure 4;𝑃 = 0.57), and therewas a trend toward
a higher TH/Vmat2 ratio in the VTA (𝑃 = 0.06).
4. Discussion
The ability to microdissect specific cells from complex,
heterogeneous tissues, such as the brain, is advantageous for
transcriptomics as it limits a potential artifact, caused by
dilution effects, that is characteristic of studies using tissue
homogenates as starting material. However, if meaningful
interpretations of transcriptomic investigations of specific
cell types or single cells are to be obtained, two important
issues need to be considered. These include sample RNA
integrity and the degree of contamination with untargeted
cells or cell fragments. We have previously developed and
demonstrated a method that preserves RNA integrity during
the immunolabeling process that is generally obligatory for
the identification of cells for microdissection [8]. In the
present study, we addressed the issue of microdissected
sample purity. Using our protocol for preservingRNAquality,
we were able to isolate an enriched and relatively pure
population of midbrain dopamine neurons. Furthermore, as
thismethod also allows for the identification and collection of
anatomically distinct subpopulations, a comparison of gene
expression between the SN and VTA dopamine neurons was
also made.
To assess the level of enrichment for dopamine neurons in
microdissected samples, dopamine neuron-associated gene
expression was compared to that in whole midbrain sec-
tions. The degree of enrichment reflects the relative num-
ber of target and nontarget cells within the section being
microdissected and the efficiency of the microdissection
process in terms of its ability to quantitatively capture all
the targeted cells. As predicted, expression levels of the
dopamine neuron-specific genes, DAT, TH, and Vmat2, and
the dopamine neuron-associated geneNURR1, were all found
to be markedly increased, relative to the 18S reference gene,
in microdissected dopamine neurons compared to whole
midbrain sections, and this was the case in both the SN
and VTA. In comparison to DAT, TH, and Vmat2, the
enrichment of NURR1 was modest, presumably reflecting
its lack of absolute specificity for dopamine neurons in the
midbrain [10, 11]. Importantly, this demonstration of marked
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Figure 4: Coexpression patterns of DAT, TH, and Vmat2 in SN
and VTA dopamine neurons. VTA dopamine neurons display a
significantly lower DAT/TH expression ratio compared to their
SN counterparts. However, there were no significant differences
in DAT/Vmat2 or TH/Vmat2 between the two dopamine neuron
populations. There was a trend towards a significantly higher
TH/Vmat2 ratio in VTA dopamine neurons (𝑃 = 0.06). Data are
expressed as mean ΔΔCt ± SEM, where the ΔCt of each gene in
each region is normalized to 18S. ΔΔCt is then determined between
the normalized genes for each region. Asterisks indicate significant
difference relative to SN. ∗𝑃 ≤ 0.05, ∗∗𝑃 ≤ 0.01; 𝑛 = 3.
enrichment underscores how readily cell-specific transcript
information could be lost if molecular profiling experiments
are carried out on tissue homogenates.
To be able to accurately attribute changes in gene
expression to a particular cell or cell type, it is important
to determine the purity of the sample. Contamination of
microdissected dopamine neuron samples by glial cell, glu-
tamate, and GABA neurons was assessed by qPCR for the
presence of Gfap, Vglut2, and Gad65 transcripts, respectively.
Transcripts for either Gfap or Vglut2 were not detected in
microdissected dopamine neuron samples, indicating that
contamination by either glial or glutamate cells did not occur
to a significant level. However, a small but significant contam-
ination by GABA neurons was found, with Gad65 transcripts
being detected in microdissected dopamine neuron samples
from both the SN and VTA. The level of GABA transcript
contamination was extremely low, being approximately 500-
fold less than the average for dopamine neuron-specific TH
transcripts in the SN, and it was not reliably detected in
all samples as the qPCR Ct value was typically close to
40. The level of GABA neuron contamination was higher
in the VTA samples, which could have resulted from an
increased difficulty to microscopically visualize, select, and
extract often smaller more clustered VTA dopamine neurons
during the laser microdissection process [2]. The source of
contamination is most likely from GABA neurons partially
overlapping the dopamine cells. During microdissection, the
target cell is separated from adjoining tissue by laser ablation,
and we directed the laser precisely to the dopamine cell body
boundary to minimize collection of adjacent nondopamine
cells during subsequent laser catapulting. However, while we
minimized the potential for contamination by overlapping
cells by using 10 micron thick cryosections, the presence
of Gad65 transcripts in the microdissected sample indicates
that this approach was not completely effective. Thinner
cryosections may resolve this contamination issue.
Our lack of evidence for Vglut2 transcripts in microdis-
sected dopamine neuron samples is somewhat surprising
given the neuroanatomical [5, 12, 13], electrophysiological [14,
15], genetic/optogenetic [16–18], and behavioral reports [19],
indicating that at least some midbrain dopamine neurons are
capable of glutamate cotransmission (for review see [20]).
However, the extent of dopamine and glutamate coexistence
as neurotransmitters in midbrain dopamine neurons is lim-
ited, with SN being devoid of Vglut2 and dorsal striatum
corelease [12, 17]. The lack of detection of Vglut2 tran-
scripts in our microdissected SN dopamine neuron samples
is consistent with these findings. With regard the VTA,
Vglut2 coexpressing dopamine neurons are mostly found
rostromedially, particularly in the rostral linear subgroup
[12]. As we microdissected a relatively small number (300) of
the total VTA dopamine neuron population (∼40,000 cells,
[4]) from representative sections throughout the rostrocaudal
extent of the VTA, it is possible that Vglut2 transcripts were
too diluted for detection. Additionally, the expression of
the glutamatergic phenotype in midbrain dopamine neurons
appears to be developmentally regulated, with essentially
nonexistent coexpression of TH and Vglut2 in either SN or
VTA of 90-day-old rats [21] and a marked reduction in mice
betweenP0 andP45 [22]. As our ratswere 4-5months old, it is
likely that there would beminimal residual Vglut2 expression
in VTA dopamine neurons.
One advantage of the immunolaser-microdissection
technique used in the present study is that it can precisely
isolate individual cells.Therefore, it was possible to accurately
collect the anatomically segregated dopamine neurons of the
SN and VTA. It is well established that dopamine neurons
of the VTA and SN and subpopulations within these nuclei
are similar with respect to the dopamine phenotype, but
distinct with regard to other properties, such as their ability to
regulate calcium [23], respond to opioids [24], and coexpress
glutamate as a neurotransmitter [12]. The ability to inves-
tigate the various subpopulations of dopamine neurons is
particularly important for studies of disease states. Consistent
with inter- and intranuclei differences, we found TH and
NURR1 expression to be significantly higher in VTA relative
to SN dopamine neurons but no differences in DAT or Vmat2
expression levels (Figure 3). Furthermore, the relative expres-
sion levels of components of the neurotransmission pathway
in dopamine neurons, namely, TH for synthesis, Vmat2 for
vesicular packaging, and DAT for cellular reuptake, can be
used to infer cell function. For example, increased dopamine
synthesis relative to cellular dopamine reuptake that is a
low DAT/TH ratio could imply relatively long transmission
duration, consistent with the known neuromodulatory, or
volume transmission, role of this neurotransmitter [2]. It
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has previously been shown that subpopulations of dopamine
neurons can display distinct patterns of dopamine gene
coexpression [2]. Using a comparative molecular analysis
of projection target-defined, midbrain dopamine neurons,
Lammel and colleagues demonstrated a significant variation
in DAT/TH and DAT/Vmat2 expression ratios across the
midbrain dopamine subgroups and showed that the differ-
ences were due to varying levels of DAT expression. All VTA
subgroups had greater levels of TH compared to DAT, and
Vmat2 expression was consistently the lowest of the three
dopamine genes [2]. In the present study, we found TH to be
the most highly expressed dopamine gene transcript, in both
the SN andVTA, withDAT having the second highest level of
expression and Vmat2 the lowest. Furthermore, we found the
ratios of DAT to TH to differ between the SN and VTA, with
there being much less DAT relative to TH in VTA compared
to SN dopamine neurons (Figure 4). This pattern of a greater
relative level of DAT compared to TH in SN is consistent with
Lammel’s findings in the mouse. Unlike Lammel, we did not
find a significant difference in DAT/Vmat2 between the SN
and VTA dopamine neurons. Another significant difference
between the Lammel and present studies is that their ratio
variances were due to DAT expression differences, whereas
ours are due to TH. When DAT expression is compared
between the two regions, there is no significant difference,
unlike TH expression, which is significantly higher in VTA
dopamine neurons (Figure 3). This probably is also why we
found no difference in the DAT/Vmat2 ratios between the
SN and VTA but a trend towards a significant difference in
TH/Vmat2 ratios. These differences between the two studies
likely reflect interspecies variations.
5. Conclusions
By combining an immunofluorescent labeling method
with laser microdissection to specifically target midbrain
dopamine neurons, this study demonstrates that large
numbers of these neurons can be extracted from separate cell
groups to produce samples enriched and relatively pure for
SN and VTA dopamine neurons. Indeed, this method could
readily be combined with existing tract tracing techniques to
allow for greater dopamine neuron subpopulation analysis.
As the method employed an immunolabeling protocol
designed to preserve high quality RNA, it also allows for
the meaningful interpretation of downstream molecular
analysis.
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